Pulmonology, Respiratory and Sleep Medicine Risk Assessment: Infection, Equipment and Escalation Controls

This assessment shows how a respiratory and sleep medicine service can identify, rate and control the risks that matter most to patient safety and care quality. Eight hazards were selected because they are plausible in everyday work on wards, in clinics, in sleep laboratories and in home care. The highest inherent scores sit with missed clinical deterioration and airborne infection, because both can cause serious harm quickly. Each hazard is scored before controls and again after existing and additional controls. Most risks fall to Low or Medium once the proposed actions are in place, though deterioration and infection stay at Medium because their impact remains serious. The first actions are a structured handover and escalation tool, fit testing and isolation checks, a ventilator and oxygen alarm review and a consent audit. This is an educational example, not clinical guidance. Any real service needs a formal, site-specific assessment led by qualified clinicians and governance staff.

Scope

This assessment covers a respiratory and sleep medicine service, including outpatient clinics, inpatient respiratory beds, a sleep laboratory and home therapy support. It looks at risks to patient safety, privacy, consent, equipment and continuity of care. It does not give clinical instruction or replace a site-specific assessment. Jurisdiction, staffing levels, equipment suppliers and record systems are assumptions made for teaching.

Context

The service has consultant pulmonologists, respiratory nurses, physiologists, sleep technologists, a ward team and administrative staff. Patients attend clinics, stay on respiratory wards, undergo bronchoscopy and sleep studies, and go home on oxygen or positive airway pressure therapy. Records sit in an electronic patient record, with monitoring equipment and ventilators feeding alarms to the ward. Each risk is scored before controls to show its natural level, then again after existing controls and the additional controls proposed here.

Objectives, assets and stakeholders

The objective is to deliver safe, timely and respectful respiratory and sleep care, prevent harm, protect privacy and keep the trust of patients and referrers. Assets in scope include patients, staff, beds and monitoring equipment, oxygen and ventilation systems, the electronic record and sleep study data. Stakeholders include patients and families, clinicians, nurses, technologists, managers, referring doctors, equipment suppliers, the governance board and regulators. Every risk has one owner role, and the clinical governance lead keeps the register current and reports to the service board each quarter.

Each risk is rated on two five-point scales. Likelihood runs from Rare to Almost certain, and impact runs from Minimal to Severe, including harm to patients. Multiplying the two gives a score from 1 to 25, placed in one of four bands: Low from 1 to 4, Medium from 5 to 9, High from 10 to 16 and Critical from 17 to 25. Inherent risk is scored before any controls. Residual risk is scored after existing and additional controls, and it must never be higher than the inherent score. Patient harm is weighted heavily, so a risk that could cause serious harm is not rated down only because it has not yet happened. Critical risks need immediate senior attention and a dated plan, High risks need a named owner and a plan within the stated timeframe, Medium risks need routine controls and checks, and Low risks are accepted and watched. Frontline staff, patients where appropriate, and a second reviewer challenge the ratings. Any indicator reaching its threshold triggers a rating review, and specialist clinical review is required before any clinical change.

Contingency arrangements

If a serious event occurs, such as an outbreak on a ward, a ventilator failure, a sentinel deterioration or a confirmed privacy breach, the duty clinical lead takes charge and makes the patient safe first. Equipment is removed from use and backup devices are brought in. Infection control, the information governance lead and the medical director are informed at once. Patients and families are told what happened early and plainly, and records are preserved. Oxygen and therapy supply is protected through a named supplier escalation route.

Conclusion

Safe respiratory and sleep care rests on steady habits: structured handovers, timely escalation, tested equipment, careful consent, tight privacy and clear records. The highest scores sit with deterioration and infection, and each has actions that bring the residual score down. Treat the register as a living record, review it on the stated cycle, and seek qualified clinical, legal and medical device advice for any real decision.